MedTrace Logo

EFFECT OF KINESIO TAPING AND LASER THERAPY IN PATIENT WITH LYMPHEDEMA ON GIRTH MEASUREMENT

NCT06808178 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-05-12

No results posted yet for this study

Summary

find out the difference in the effect of kinesio taping and low level laser therapy on 66 patients with post mastectomy lymphedema as regards the following outcomes:

1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.

Conditions

  • Lymphedema
  • Breast Cancer Stage II

Interventions

DEVICE

Low Level Laser Therapy

The device has the following treatment parametes : * Maximum average power \> 500 milli watts * Wave length combined (904-808) nm * Maximum repition rate (1-2000) Hz * Energy density : 4:6 J per cm per session

OTHER

kinesio taping

* the material used is 100%acrylic,latex free and heat activated with 10-15% stretch. * It is made of 100% cotton to allow quickening of the drying process. * Ability to stretch to 120-140% of its original length * Recoil back to the anchor that is applied without stretch * Heat-activated adhesive * Hypoallergenic dyes that make the tape safe for most users * Latex-free * Drying time after being wet is about 5-10 minutes * Can be worn for several days

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • MERIT MAGDY ZAKI, physiotherapist · beni suif university

  • SHERIN HASSAN MEHANI, Professor of Physical therapy · beni suif university

  • MAHMOUD AWD ELKHOLY, Lecturer of physical therapy · beni suif university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2025-06-01
Completion
2025-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06808178 on ClinicalTrials.gov